These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9849146)

  • 41. Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.
    Teipel SJ; Alexander GE; Schapiro MB; Möller HJ; Rapoport SI; Hampel H
    Brain; 2004 Apr; 127(Pt 4):811-24. PubMed ID: 14985261
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Neurological complications in Down's Syndrome].
    Lev N; Melamed E
    Harefuah; 2002 Sep; 141(9):820-3, 857. PubMed ID: 12362489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cytogenetic study and chromosome abnormalities of Alzheimer's disease and Down's syndrome].
    Asaka A
    Nihon Rinsho; 1988 Jul; 46(7):1502-7. PubMed ID: 2975715
    [No Abstract]   [Full Text] [Related]  

  • 44. microRNA 155 up regulation in the CNS is strongly correlated to Down's syndrome dementia.
    Tili E; Mezache L; Michaille JJ; Amann V; Williams J; Vandiver P; Quinonez M; Fadda P; Mikhail A; Nuovo G
    Ann Diagn Pathol; 2018 Jun; 34():103-109. PubMed ID: 29661714
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The aging of Down's Syndrome subjects].
    Fromage B; Anglade P
    Encephale; 2002; 28(3 Pt 1):212-6. PubMed ID: 12091781
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alzheimer's disease, Down's syndrome, and chromosome 21.
    Lancet; 1987 May; 1(8540):1011-2. PubMed ID: 2883347
    [No Abstract]   [Full Text] [Related]  

  • 47. Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia.
    Royston MC; Mann D; Pickering-Brown S; Owen F; Perry R; Raghavan R; Khin-Nu C; Tyrer S; Day K; Crook R
    Neuroreport; 1994 Dec; 5(18):2583-5. PubMed ID: 7696609
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age-related neuropsychological deficits in Down's syndrome.
    Thase ME; Tigner R; Smeltzer DJ; Liss L
    Biol Psychiatry; 1984 Apr; 19(4):571-85. PubMed ID: 6234031
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Presenile dementia associated with unbalanced Robertsonian translocation form of Down's syndrome.
    Prasher VP
    Lancet; 1993 Sep; 342(8872):686-7. PubMed ID: 8103177
    [No Abstract]   [Full Text] [Related]  

  • 50. Alzheimer's disease: genetic aspects and associated clinical disorders.
    Heyman A; Wilkinson WE; Hurwitz BJ; Schmechel D; Sigmon AH; Weinberg T; Helms MJ; Swift M
    Ann Neurol; 1983 Nov; 14(5):507-15. PubMed ID: 6228188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Cerebral degeneration in Down's syndrome].
    Hirabayashi K; Ikeda K; Shimokawa K; Orthner H
    Folia Psychiatr Neurol Jpn; 1979; 33(1):81-96. PubMed ID: 156670
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alzheimer's disease in Down's syndrome: visual retention deficits.
    Dalton AJ; Crapper DR; Schlotterer GR
    Cortex; 1974 Dec; 10(4):366-77. PubMed ID: 4281378
    [No Abstract]   [Full Text] [Related]  

  • 53. The influence of apolipoprotein E isotypes on Alzheimer's disease pathology in 40 cases of Down's syndrome.
    Wisniewski T; Morelli L; Wegiel J; Levy E; Wisniewski HM; Frangione B
    Ann Neurol; 1995 Jan; 37(1):136-8. PubMed ID: 7818249
    [No Abstract]   [Full Text] [Related]  

  • 54. Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients.
    Blusztajn JK; Lopez Gonzalez-Coviella I; Logue M; Growdon JH; Wurtman RJ
    Brain Res; 1990 Dec; 536(1-2):240-4. PubMed ID: 2150771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetics of Down's syndrome and Alzheimer's disease.
    Shamas-Ud-Din S
    Br J Psychiatry; 2002 Aug; 181():167-8; author reply 168. PubMed ID: 12151296
    [No Abstract]   [Full Text] [Related]  

  • 56. The genetics of Alzheimer's disease: associations with hematologic malignancy and Down's syndrome.
    Heston LL; Mastri AR
    Arch Gen Psychiatry; 1977 Aug; 34(8):976-81. PubMed ID: 142459
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alzheimer's disease in Down's syndrome: clinicopathologic studies.
    Wisniewski KE; Dalton AJ; McLachlan C; Wen GY; Wisniewski HM
    Neurology; 1985 Jul; 35(7):957-61. PubMed ID: 3159974
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alzheimer's disease, Down's syndrome, and aging: the genetic approach.
    Sinex FM; Myers RH
    Ann N Y Acad Sci; 1982; 396():3-13. PubMed ID: 6217775
    [No Abstract]   [Full Text] [Related]  

  • 59. Down's syndrome and Alzheimer's disease: a review.
    Oliver C; Holland AJ
    Psychol Med; 1986 May; 16(2):307-22. PubMed ID: 2941815
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Down's syndrome: prophylaxis and therapy for the frequently comorbid Alzheimer's disease.
    Oken RJ; McGeer PL
    Med Hypotheses; 1995 Apr; 44(4):233-4. PubMed ID: 7666820
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.